Task: Answer the MCQ question.
Question: Which drug exhibits a -22.969% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a CC(=O)N1CCc2cc(S(=O)(=O)NCCC(=O)NC3CCCCCC3)ccc21
b CC1CN(S(=O)(=O)c2cccc(C(=O)N(Cc3nnc(-c4ccccc4Cl)o3)C3CC3)c2)CC(C)O1
c Cc1cc(CN2CCCC(C(=O)Nc3cccc(-n4cccn4)c3)C2)cc(C)c1O
d CCOn1c(=O)c(=O)n(OC)c2ccccc21
e COc1ccc(N2CCCn3c2nc2c3c(=O)n(Cc3ccccc3)c(=O)n2C)c(OC)c1
Answer: a. CC(=O)N1CCc2cc(S(=O)(=O)NCCC(=O)NC3CCCCCC3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)N1CCc2cc(S(=O)(=O)NCCC(=O)NC3CCCCCC3)ccc21
CC(=O)N1CCc2cc(S(=O)(=O)NCCC(=O)NC3CCCCCC3)ccc21
3-[(1-acetyl-2,3-dihydroindol-5-yl)sulfonylamino]-N-cycloheptylpropanamide